Glucocorticoids in the management of Neurological Emergencies
Glucocorticoids are widely used in veterinary practice for the management (mismanagement!!) of spinal cord trauma. Glucocorticoids may reduce inflammation, however, they can also prejudice the survival of any injured neurons by interfering with their glucose metabolism (Sapolsky, 1994; Smith-Swintosky et al, 1996). In particular, the use of dexamethasone has been associated with a poorer prognosis in patients with spinal injury. In addition, there is almost certainly no neuroprotective benefit provided by any corticosteroid, with the possible exception of methylprednisolone sodium succinate.
The use of methylprednisolone sodium succinate in veterinary medicine is based on human data (Bracken MB et al, 1990), although many studies have now raised serious questions about the value of methylprednisolone sodium succinate in humans, reporting extensive complications with minimal neurological gain. There are NO veterinary studies to demonstrate benefits following the use of methylprednisolone sodium succinate. The benefits reported originally in man were relatively small improvements mainly associated with upper-body function, e.g. improved dexterity of digits. Whilst these relatively small changes may be important in people, they are of little value in animals. It is worth noting that the use of methylprednisolone in humans more than 8 hours following spinal cord injury actually worsens the prognosis, presumably due to interference with neuronal glucose metabolism, as previously described. There is no reason to believe this may not be the case in animals, and possibly in a relatively shorter time.
Corticosteroids can precipitate clinically significant gastrointestinal bleeding in as many as 15% of neurosurgical patients, with mortality rates up to 2%. Dexamethasone is most likely to cause problems and has no role in the management of spinal trauma. Furthermore, dexamethasone may actually exacerbate spinal cord injury. With the current body of knowledge, the use of dexamethasone in the management of spinal cord trauma would not only be unwise; it may well be considered negligent.
Duodenal or colonic perforations are the most serious potential gastrointestinal complications following corticosteroid use. (Toombs et al., 1986; Hinton et al., 2002). It is important to note that standard gastrointestinal protectant agents may not be effective in preventing corticosteroid-induced side effects (Hansen et al, 1997). In one study endoscopy revealed severe, subclinical gastrointestinal hemorrhage in 90% of dogs after methylprednisolone sodium succinate treatment (Rohrer et al.,1999). For all of the above reasons, routine glucocorticoid therapy in spinal patients is strongly discouraged (LeCouteur and Sturgess, 2003).
Ok, so we don't use corticosteroids for spinal patients… but what about intracranial injury… surely we should use corticosteroids for the management of head trauma??
The role of corticosteroids in the management of head trauma has been widely researched, and their use is not recommended. Clinical trials have not shown a beneficial effect of corticosteroids, including methylprednisolone sodium succinate, in the treatment of head injury. In addition, they have been associated with increased risks of infection, are immunosuppressive, cause hyperglycemia leading to cerebral acidosis, and have other significant deleterious effects on metabolism.